encephalitis

Documents about encephalitis

• EURopean Study on Encephalitis in Intensive CAre#1339914ClinicalTrials.gov
• Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis.#914707ClinicalTrials.gov
• The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis#1464739ClinicalTrials.gov
• Study of Acute Autoimmune Encephalitis With Positive Antibodies in Eastern France#1044510ClinicalTrials.gov
• Clinicolaboratory Predictors of Outcome in Children With Encephalitis#878773ClinicalTrials.gov
• Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis)#891477ClinicalTrials.gov
• Medium-term Effects of Treatments in Autoimmune Encephalitis#1474668ClinicalTrials.gov
• CPI Combination Therapy for Autoimmune Encephalitis#893063ClinicalTrials.gov
• A Multicentric Cohort of Autoimmune Encephalitis#1455049ClinicalTrials.gov
• CASPR2 Encephalitis Initial Symptoms#885051ClinicalTrials.gov
• VRC 313: A Trivalent Virus-like Particle (VLP) Encephalitis Vaccine (WEVEE) in Healthy Adults#668858ClinicalTrials.gov
• HLA Analysis in Autoimmune Encephalitis and Related Disorders#1371056ClinicalTrials.gov
• The NOrwegian Tick-borne Encephalitis Study#1279735ClinicalTrials.gov
• Treatment of Japanese Encephalitis#1395924ClinicalTrials.gov
• A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis#907121ClinicalTrials.gov
• A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 Encephalitis#1075462ClinicalTrials.gov
• Efficacy of Tacrolimus and I.V.-Immunoglobulins in Rasmussen Encephalitis#1410859ClinicalTrials.gov
• Tick-borne Encephalitis and Positive Borrelial Antibodies#311155ClinicalTrials.gov
• IL-2 in Refractory Autoimmune Encephalitis#993958ClinicalTrials.gov
• QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study#1112162ClinicalTrials.gov
• Dexamethasone in Tick-borne Encephalitis#1231429ClinicalTrials.gov
• Long Term Treatment of Herpes Simplex Encephalitis (HSE) With Valacyclovir#1085811ClinicalTrials.gov
• Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Toddlers#1030233ClinicalTrials.gov
• Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis Collection#832169ClinicalTrials.gov
• Diagnostics and Surveillance of Acute Meningo-encephalitis Among Children in Cambodia With a Focus on Japanese Encephalitis Virus#884522ClinicalTrials.gov
• Evolving Diagnostic Approaches to Undocumented Lymphocytic Meningitis and Meningoencephalitis#1438710ClinicalTrials.gov
• Tick-borne Encephalitis and Borrelial Antibodies in Serum#121408ClinicalTrials.gov
• QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study 001#802333ClinicalTrials.gov
• Predicting and Monitoring Outcomes in Autoimmune Encephalitis#813118ClinicalTrials.gov
• Immunogenicity Study of the Japanese Encephalitis Vaccine IC51#878981ClinicalTrials.gov
• Diffusion Imaging in Acute Auto-immune Encephalitis#825553ClinicalTrials.gov
• A Clinical Trial for Inactivated Japanese Encephalitis Vaccine in Healthy Chinese Infants#1172231ClinicalTrials.gov
• Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis#1429828ClinicalTrials.gov
• Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)#1407522ClinicalTrials.gov
• Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners in France#1058999ClinicalTrials.gov
• Risk Factors and Outcomes of Immune-Mediated Encephalitis Following Exposure to Nivolumab#830228ClinicalTrials.gov
• Clinical Evaluation of the FilmArray® Meningitis/Encephalitis (ME) Panel#855558ClinicalTrials.gov
• Tick-borne Encephalitis and Possible Borrelial Serology#1140420ClinicalTrials.gov
• Effect of Erythropoietin in Refractory Autoimmune Encephalitis Patients#1438908ClinicalTrials.gov
• Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai Children#1454270ClinicalTrials.gov
• Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population#992411ClinicalTrials.gov
• Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440#1007490ClinicalTrials.gov
• Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51#1100680ClinicalTrials.gov
• Incidence of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis#1170807ClinicalTrials.gov
• Vaccine Study for Tick-Borne Encephalitis Virus (TBEV)#1376251ClinicalTrials.gov
• Acute Infectious Encephalitis and Myelitis in Guadeloupe by New Generation Sequencing#1363135ClinicalTrials.gov
• A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease#889908ClinicalTrials.gov
• New Biomarkers in Auto-immune Encephalitis and Neurological Paraneoplastic Syndromes#121345ClinicalTrials.gov
• Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis#200215ClinicalTrials.gov
• Efficacy and Safety of Adjunctive Minocycline in the Treatment of Autoimmune Encephalitis#843480ClinicalTrials.gov